As a key member of our innovation team, you will play a vital role in advancing our company's innovation strategy. This position requires a unique blend of technical expertise and business acumen to drive the evaluation and development of new opportunities.
You will lead the technical evaluation of new business development opportunities, assessing scientific soundness, development feasibility, and potential risks. This will involve collaborating with cross-functional teams, including R&D, Clinical Development, Regulatory Affairs, and Intellectual Property, to inform project assessments and align on strategy.
Additionally, you will identify, analyze, and present emerging technologies, platforms, or trends that may offer strategic benefit to the organization. Your insights and recommendations will directly support strategic decision-making and resource allocation, helping to maintain our competitive edge and commitment to innovation across therapeutic areas.
By contributing to the identification and integration of external innovations, you will help ensure we continue to lead in the development of accessible and transformative healthcare solutions worldwide.
Required Skills & Qualifications
This role offers a unique opportunity to work at the forefront of healthcare innovation, driving the development of cutting-edge technologies and therapies. As a key member of our team, you will have the chance to contribute to the creation of life-changing solutions and make a lasting impact on the lives of patients worldwide.
Others
Travel to scientific meetings, congresses, and partner sites may be required. Familiarity with intellectual property landscapes and patent evaluation is a plus. Global perspective on healthcare innovation trends and technologies is also highly valued.
* The salary benchmark is based on the target salaries of market leaders in their relevant sectors. It is intended to serve as a guide to help Premium Members assess open positions and to help in salary negotiations. The salary benchmark is not provided directly by the company, which could be significantly higher or lower.